Virtual 2021

Browse: Pre-Congress Content Sunday, 05.09.2021 Monday, 06.09.2021 Tuesday, 07.09.2021 Wednesday, 08.09.2021		View the presentations you missed during Congress! More than 1'200 webcasts and slide presentations, 2'300 e-posters and , 3'000 abstracts from the Virtual Congress 2021 and are now available.

Citations should be made in the following way: Authors. Title. Eur Respir J 2021; 58: Suppl. 65, abstract number.

Airway diseases

State of the art session
Chairs: O. Usmani (London, United Kingdom), A. Yorgancioglu (Konak, Turkey)
Aims: To evaluate the use of short-acting ß-2 agonist (SABA) monotherapy versus maintenance and reliever therapy (MART) and triple therapy for asthma; to describe new treatments for chronic cough; to determine the optimal endoscopic procedure for different patients with chronic obstructive pulmonary disease (COPD) and asthma; to discuss the role of artificial intelligence in asthma and COPD treatment.

Download all media

How to treat asthma in 2021? Goodbye SABA, hello MART and welcome triple therapy A. Papi (Ferrara, Italy)
New treatments for chronic cough J. Smith (Manchester (Greater Manchester), United Kingdom)
Which endoscopic procedure to use and in what patient? Valves, coils, foam and heat in COPD and asthma L. Pyng (Singapore, Singapore)
Will artificial intelligence really transform clinical practice? Applications in asthma and COPD K. Kostikas (Ioannina, Greece)
Discussion and Q&A